Home › FDA Approves New Drug Application (NDA) For Teva's Quartette (Levonorgestrel/Ethinyl Estradiol And Ethinyl Estradiol) Tablets For The Prevention Of Pregnancy
 

Keywords :   


FDA Approves New Drug Application (NDA) For Teva's Quartette (Levonorgestrel/Ethinyl Estradiol And Ethinyl Estradiol) Tablets For The Prevention Of Pregnancy

2013-03-29 09:00:00| drugdiscoveryonline News Articles

Teva Pharmaceutical Industries Ltd. recently announced that the U.S. Food and Drug Administration (FDA) has approved Quartette™ (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy

Tags: the of application drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
23.06Atlantic Tropical Weather Outlook
23.06What are my rights if my flight is cancelled or delayed?
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
23.06British Gas sorry for pursuing man over wrong 2,500 bill
23.06Airport 'stay away' warning amid major power cut
More »